Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Our Semaglutide program is a monthly membership designed and supervised by our APRN providers
Report suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
Overall Health General health status and the presence of other medical conditions can impact the speed of results
Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription medication sold under Novo Nordisks brands Ozempic, approved for diabetes management, and Wegovy, which is approved by Health Canada for weight loss
Some patients may ask about switching from semaglutide to tirzepatide if weight loss slows, side effects become difficult, blood sugar goals change, or they are not seeing the desired response
